StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Worst year in the stock market since 2008

<< Previous

Bullboard Posts

Next >>

Post by Nailbiter2on Dec 29, 2022 10:07am

178 Views

Post# 35195076

Worst year in the stock market since 2008

L2T can stop crying about tax loss selling.
All signs point to "ain't gonna happen".
So far, insiders are holding tight.

The 2022 Tax-Loss Harvesting Deadline Is Looming: What to Buy With Your Proceeds. Mark the calendar for December 28. That's the last day to sell stocks at a loss for for tax-loss harvesting this year. The last day to trade for a loss is not December 31, because it's the settlement date that counts.